Identification of Biomarkers in Spinocerebellar Ataxia 3
Study Description
“Identification of Biomarkers in Spinocerebellar Ataxia 3”
The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for treatment or prevention of this condition.
Location
Methods
No pharmaceutical medication involved
Patients and healthy individuals accepted
Specimen Collection
No interventions take place as part of study participation- only specimen collection occurs for both cohorts.
Additional Information
Official Study Title
Identification of Biomarkers in Spinocerebellar Ataxia 3
Clinical Trial ID
NCT03885167
ParticipAid ID
en5XPd
